Dave Muoio

By Dave Muoio 02:06 pm July 31, 2020
Lemonaid Health, a San Francisco-based telehealth platform and provider, announced today $33 million in Series B funding. The new round was led by Olive Tree Ventures, and included Artis Ventures, Correlation Ventures, Hikma Ventures, Sierra Ventures and other unnamed backers. This latest round brings the company's fundraising total to $55 million. Lemonaid said it will be using the new funds to...
By Dave Muoio 02:49 pm July 30, 2020
D2C wellness and telehealth startup Hims & Hers is looking to cut down the time between medication orders and delivery for certain customers. Thanks to a newly announced partnership, patients receiving virtual primary care services through Hims & Hers may choose to select Alto as their preferred pharmacy for prescription deliveries. They will have their orders fulfilled automatically ...
By Dave Muoio 01:29 pm July 30, 2020
Teladoc Health continues its strong upward trend during its second fiscal quarter, with CEO Jason Gorevic informing investors yesterday that the company had outperformed "all key financial and operation metrics." Similar to the first quarter, the telehealth company is touting massive year-over-year (YoY) growth in revenue, visit volume and new registrations, as well as the acquisition of several...
By Dave Muoio 02:52 pm July 29, 2020
Sema4, a Mount Sinai spinout developing health-data-analytics platforms, has raised $121 million in Series C funding. BlackRock led the oversubscribed round, which also saw participation from new investors Deerfield Management Company and Moore Strategic Ventures, and also old backers Blackstone, Section 32, Oak HC/FT, Decheng and Connecticut Innovations. With this round, coming less than a year...
By Dave Muoio 12:14 pm July 29, 2020
A retrospective analysis of more than 2,000 Livongo Diabetes Prevention Program (DPP) participants found an average weight loss of 5.1% from baseline after 12 months, and 6.6% among those who designated as high engagers. The study, conducted by Livongo and published in BMJ Open Diabetes Research & Care, honed in on the relationships between specific program behaviors and program engagement...
By Dave Muoio 08:38 am July 29, 2020
Humana has invested $100 million into Heal as part of a new strategic partnership between the two companies. The Series D investment more than doubles Heal's lifetime fundraise, bringing the house call and telehealth platform's lifetime raise to around $170 million. WHAT IT DOES Heal was founded in 2015 as an app that helped users coordinate doctor house calls. Although initially limited to Los...
By Dave Muoio 11:41 am July 28, 2020
Israeli "digital X-ray" startup Nanox has secured another $59 million from unnamed "global investors." The company now pegs its round total at $110 million, after combining today's news with investments announced since November of 2019. Contributors to those incremental raises included Foxconn, Fujifilm and SK Telecom. WHAT IT DOES The Israeli company is developing a two-pronged offering...
By Dave Muoio 03:00 am July 28, 2020
Withings, a maker of several consumer and B2B connected health devices once owned by Nokia, has announced the close of a $60 million Series B round. The raise was co-headed by Gilde Healthcare, Idinvest Partners and Bpifrance. BNP Paribas Développement, ODDO BHF Private Equity and Adelie Capital also participated. The company has also appointed a new global medical advisory board that includes Dr...
By Dave Muoio 02:15 pm July 27, 2020
On Friday evening, the FDA reissued an emergency use authorization (EUA) for LabCorp's COVID-19 RE-PCR Test that now allows for testing among those without any symptoms of COVID-19. The agency also expanded the indication to allow for pooled sample testing – a technique of combining multiple samples into a single test, and then following up with individual tests should the group be positive. The...
By Dave Muoio 02:56 pm July 24, 2020
Abbott has received FDA approval for a neuromodulation system-controller app that runs on iOS devices, the company announced Thursday. Compatible with Abbott's broader NeuroSphere Digital Care platform, the Patient Controller app replaces the separate device patients use to adjust the company's neuromodulation products. These include the Infinity DBS System for Parkinson's disease or essential...